Get started
Author

T. Zwingers

Observed names: T Zwingers, T. H. Zwingers, Theodor Zwingers, Zwingers, T.
Observed institutions: University of Vienna, Universität Hamburg, University of Cologne, Friedrich-Alexander-Universität Erlangen-Nürnberg, Heidelberg University, University of Münster, University Hospital Heidelberg, TUM Klinikum, Robert Bosch Hospital, Medizinische Hochschule Hannover, Universitätsklinikum Erlangen, Hanusch Hospital, Luisenkrankenhaus, RoMed Kliniken, University Hospital Frankfurt, Allergy Therapeutics (United Kingdom), Pharmalog (Germany), Heinrich Heine University Düsseldorf, University of Regensburg, Technical University of Munich, Medical University of Vienna, Charité – Universitätsmedizin Berlin, Ludwig-Maximilians-Universität München, University of Lübeck
OpenAlex ID: A5111496151
Clinical and prognostic relevance of the Kiel classification of non‐Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group
1984 · G. Brittinger, H. Bartels, et al. · Hematological Oncology · 207
Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study
2005 · S. Radakovic-Fijan, U. Blecha-Thalhammer, et al. · British Journal of Dermatology · 82
Effective natural interferon-alpha therapy in recombinant interferon- alpha-resistant patients with hairy cell leukemia
1991 · P von Wussow, H Pralle, et al. · Blood · 76
Disappointing results and low tolerability of photodynamic therapy with topical 5‐aminolaevulinic acid in psoriasis. A randomized, double‐blind phase I/II study
2006 · V Schleyer, S Radakovic‐Fijan, et al. · Journal of the European Academy of Dermatology and Venereology · 51
Serum Levels of Soluble CD23, but not Soluble CD25, Predict Disease Progression in Early Stage B-Cell Chronic Lymphocytic Leukemia
1997 · W. U. Knauf, I. Langenmayer, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 43
Klinische und prognostische Relevanz der Kiel-Klassifikation der Non-Hodgkin-Lymphome
2009 · G. Brittinger, H. Bartels, et al. · Onkologie · 26
Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia
1990 · AD Ho, M Grossman, et al. · Blood · 17
PDF
Plasma levels of soluble CD8 antigen and interleukin-2 receptor antigen in patients with hairy cell leukemia, relationship with splenectomy and with clinical response to therapy.
1989 · A D Ho, M Grossmann, et al. · PubMed · 14
A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomy.
1987 · H Pralle, T Zwingers, et al. · PubMed · 13
Prognostic Impact of the Serum Levels of Soluble CD23 in B-Cell Chronic Lymphocytic Leukemia
1997 · Irmgard Langenmayer, Michael Hallek, et al. · Blood · 12
[DMSO in patients with active gonarthrosis. A double-blind placebo controlled phase III study].
1995 · R Eberhardt, T Zwingers, et al. · PubMed · 12
Chronic Lymphocytic Leukemia (B-CLL) and Immunocytoma (LP-IC): Clinical and Prognostic Relevance of this Distinction
1991 · M. Engelhard, G. Brittinger, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 12
Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study
2016 · W Janni, N Harbeck, et al. · British Journal of Cancer · 11
PDF
Long-term therapy with the new glucocorticosteroid deflazacort in rheumatoid arthritis. Double-blind controlled randomized 12-months study against prednisone.
1994 · R Eberhardt, K Krüger, et al. · PubMed · 9
[Acrylonitrile--epidemiological study--Bayer 1977: a report on a prospective epidemiological study with a past beginning of coworkers at the Leverkusen plant of Bayer AG with acrylonitrile (ACN) exposure].
1979 · N Kiesselbach, U Korallus, et al. · PubMed · 9
Therapie der Detrusorhyperaktivität mit Propiverin
2005 · S. Alloussi, M. Goepel, et al. · Der Urologe · 7
Patientenrekrutierung und Ergebnisse einer Vorphasestudie zur Therapie der akuten lymphatischen Leukämie und der akuten undifferenzierten Leukämie des Erwachsenen
2009 · D. Hoelzer, E. Thiel, et al. · Onkologie · 6
Abstract S2-2: Multivariate Analysis of Obesity and Disease Free Survival in Patients with Nodal Positive Primary Breast Cancer — The ADEBAR Trial
2010 · PGM Hepp, B Rack, et al. · Cancer Research · 4
Primäre Behandlung der Haarzelleukämie mit niedrigdosiertem humanem rekombinantem Interferon-Alpha-2c (Hr-IFn Alpha 2c) im Vergleich zur Therapie nach Splenektomie
2009 · H. Pralle, T. Zwingers, et al. · Onkologie · 4
Graft manipulation prior to small intestinal transplantation.
1989 · M Gundlach, P Schroeder, et al. · PubMed · 4
Multizentrische prospektive risikoadaptierte Studie zur Therapie von Non-Hodgkin-Lymphomen hoher Malignität
2009 · W. Siegert, D. Huhn, et al. · Onkologie · 3
Correspondence
1991 · A C Feller, K Lennert, et al. · Histopathology · 3
Zentrozytisches Lymphom: klinisches Bild und Analyse der bisherigen Therapieerfahrungen
1989 · M. Engelhard, P. Meusers, et al. · De Gruyter eBooks · 3
Risk Groups in Adult Acute Lymphoblastic Leukemia
1987 · D. Hoelzer, E. Thiel, et al. · Hämatologie und Bluttransfusion · 3
Interferon α für die Therapie der HCL
2009 · H. Pralle, A. Bartel, et al. · Onkologie · 2
Works count: 49
Citation count: 640
H-index: 12
I10-index: 13
Year
Topic
Type